closeCreated with sketchtool.
Show all results

Consolidated Cash Flow Statement

30 KB EXCEL

€ million Note 2018 2017
Profit after tax1 3,396 2,615
Depreciation/amortization/impairment losses/reversals of impairments 1,812 1,758
Changes in inventories – 172 – 184
Changes in trade accounts receivable – 109 – 221
Changes in trade accounts payable/refund liabilities 104 234
Changes in provisions 199 103
Changes in other assets and liabilities – 288 – 1,256
Neutralization of gains/losses on disposal of assets – 2,733 – 346
Other non-cash income and expenses1 11 – 7
Net cash flows from operating activities ➞ 18 2,219 2,696
thereof: from discontinued operation 24 103
 
Payments for investments in intangible assets – 106 – 392
Payments from the disposal of intangible assets 67 4
Payments for investments in property, plant and equipment – 910 – 919
Payments from the disposal of property, plant and equipment 31 44
Payments for investments in financial assets – 75 – 219
Payments for acquisitions less acquired cash and cash equivalents – 17
Payments from the disposal of other financial assets 55 185
Payments from other divestments less transferred cash and cash equivalents 11
Payments from the disposal of assets held for sale
less transferred cash and cash equivalents
3,129 156
Net cash flows from investing activities ➞ 31 2,191 – 1,147
thereof: from discontinued operation 3,042 – 42
 
Dividend payments to shareholders of Merck KGaA, Darmstadt, Germany – 162 – 155
Dividend payments to non-controlling interests – 13 – 4
Dividend payments to E. Merck KG, Darmstadt, Germany – 593 – 466
Payments from new borrowings of financial liabilities from E. Merck KG, Darmstadt, Germany 375 349
Repayment of financial liabilities to E. Merck KG, Darmstadt, Germany – 319 – 314
Repayment of bonds – 323 – 932
Payments from new borrowings of other current and non-current financial liabilities 32 147
Repayment of other current and non-current financial liabilities – 1,821 – 496
Net cash flows from financing activities ➞ 41 – 2,825 – 1,870
thereof: from discontinued operation 5 182
 
Changes in cash and cash equivalents 1,586 – 320
Changes in cash and cash equivalents due to currency translation – 5 – 30
Cash and cash equivalents as of January 1 589 939
Cash and cash equivalents as of December 31 (consolidated balance sheet) ➞ 33 2,170 589
1
Previous year’s figures have been adjusted, see Note (49) ‟Effects from new accounting standards and other presentation and measurement changes”.